Aprea Therapeutics, Inc. (APRE) vs Azitra, Inc. (AZTR)
Aprea Therapeutics, Inc. and Azitra, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and Azitra, Inc. are of similar size ($10.1M and $9.8M). Aprea Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −81.0%. Across the 13 metrics below, Azitra, Inc. leads on 7 and Aprea Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | APRE | AZTR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (47.44%) | (256.67%) | (57.72%) |
| Return on assets | (41.30%) | (190.69%) | (49.22%) |
| Return on invested capital | 0.00% | (1,272.49%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack